288 related articles for article (PubMed ID: 22417013)
21. Steroid hormone receptors in normal, dysplastic and neoplastic feline mammary tissues and their prognostic significance.
Millanta F; Calandrella M; Vannozzi I; Poli A
Vet Rec; 2006 Jun; 158(24):821-4. PubMed ID: 16782855
[TBL] [Abstract][Full Text] [Related]
22. Activation of AKT in feline mammary carcinoma: a new prognostic factor for feline mammary tumours.
Maniscalco L; Iussich S; de Las Mulas JM; Millán Y; Biolatti B; Sasaki N; Nakagawa T; De Maria R
Vet J; 2012 Jan; 191(1):65-71. PubMed ID: 21282070
[TBL] [Abstract][Full Text] [Related]
23. Correlation of vascular endothelial growth factor expression to overall survival in feline invasive mammary carcinomas.
Millanta F; Lazzeri G; Vannozzi I; Viacava P; Poli A
Vet Pathol; 2002 Nov; 39(6):690-6. PubMed ID: 12450199
[TBL] [Abstract][Full Text] [Related]
24. Clinicopathological significance of immunoexpression of claudin-1 and claudin-7 in feline mammary carcinomas.
Flores AR; Rêma A; Carvalho F; Lopes G; Faustino A; Dias Pereira P
J Comp Pathol; 2014 Nov; 151(4):339-46. PubMed ID: 25246182
[TBL] [Abstract][Full Text] [Related]
25. Immunohistochemical Expression Profiles of Cell Adhesion Molecules, Matrix Metalloproteinases and their Tissue Inhibitors in Central and Peripheral Neoplastic Foci of Feline Mammary Carcinoma.
Pisamai S; Rungsipipat A; Kunnasut N; Suriyaphol G
J Comp Pathol; 2017; 157(2-3):150-162. PubMed ID: 28942298
[TBL] [Abstract][Full Text] [Related]
26. Expression of TopBP1 in canine mammary neoplasia in relation to histological type, Ki67, ERalpha and p53.
Morris JS; Nixon C; King OJ; Morgan IM; Philbey AW
Vet J; 2009 Mar; 179(3):422-9. PubMed ID: 18314357
[TBL] [Abstract][Full Text] [Related]
27. Immunohistochemical analysis of cyclin A, cyclin D1 and P53 in mammary tumors, squamous cell carcinomas and basal cell tumors of dogs and cats.
Murakami Y; Tateyama S; Rungsipipat A; Uchida K; Yamaguchi R
J Vet Med Sci; 2000 Jul; 62(7):743-50. PubMed ID: 10945293
[TBL] [Abstract][Full Text] [Related]
28. Expression of NOS and VEGF in feline mammary tumours and their correlation with angiogenesis.
Islam MS; Matsumoto M; Hidaka R; Miyoshi N; Yasuda N
Vet J; 2012 Jun; 192(3):338-44. PubMed ID: 22154426
[TBL] [Abstract][Full Text] [Related]
29. [The expression and significance of trefoil factor 3 and SDF-1/CXCR4 biological axis in papillary thyroid carcinoma].
Xue G; Huang J; Zhang H; Zhang W; Wu J; Shang X
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Jan; 28(2):108-12. PubMed ID: 24738314
[TBL] [Abstract][Full Text] [Related]
30. Effects of SDF-1-CXCR4 signaling on microRNA expression and tumorigenesis in estrogen receptor-alpha (ER-α)-positive breast cancer cells.
Rhodes LV; Bratton MR; Zhu Y; Tilghman SL; Muir SE; Salvo VA; Tate CR; Elliott S; Nephew KP; Collins-Burow BM; Burow ME
Exp Cell Res; 2011 Nov; 317(18):2573-81. PubMed ID: 21906588
[TBL] [Abstract][Full Text] [Related]
31. Prognostic histopathological and molecular markers in feline mammary neoplasia.
Hughes K; Dobson JM
Vet J; 2012 Oct; 194(1):19-26. PubMed ID: 22841451
[TBL] [Abstract][Full Text] [Related]
32. Comparative value of clinical, cytological, and histopathological features in feline mammary gland tumors; an experimental model for the study of human breast cancer.
Shafiee R; Javanbakht J; Atyabi N; Bahrami A; Kheradmand D; Safaei R; Khadivar F; Hosseini E
Diagn Pathol; 2013 Aug; 8():136. PubMed ID: 23941603
[TBL] [Abstract][Full Text] [Related]
33. Reduced PTEN protein expression and its prognostic implications in canine and feline mammary tumors.
Ressel L; Millanta F; Caleri E; Innocenti VM; Poli A
Vet Pathol; 2009 Sep; 46(5):860-8. PubMed ID: 19429983
[TBL] [Abstract][Full Text] [Related]
34. CXCR4-SDF-1 signalling, locomotion, chemotaxis and adhesion.
Kucia M; Jankowski K; Reca R; Wysoczynski M; Bandura L; Allendorf DJ; Zhang J; Ratajczak J; Ratajczak MZ
J Mol Histol; 2004 Mar; 35(3):233-45. PubMed ID: 15339043
[TBL] [Abstract][Full Text] [Related]
35. First description of feline inflammatory mammary carcinoma: clinicopathological and immunohistochemical characteristics of three cases.
Pérez-Alenza MD; Jiménez A; Nieto AI; Peña L
Breast Cancer Res; 2004; 6(4):R300-7. PubMed ID: 15217496
[TBL] [Abstract][Full Text] [Related]
36. Nuclear cytomorphometry in feline mammary gland epithelial tumours.
Simeonov R; Simeonova G
Vet J; 2009 Feb; 179(2):296-300. PubMed ID: 17959399
[TBL] [Abstract][Full Text] [Related]
37. Expression of E-cadherin in normal, hyperplastic and neoplastic feline mammary tissue.
Dias Pereira P; Gärtner F
Vet Rec; 2003 Sep; 153(10):297-302. PubMed ID: 14509576
[TBL] [Abstract][Full Text] [Related]
38. Cell proliferation in feline normal, hyperplastic and neoplastic mammary tissue--an immunohistochemical study.
Dias Pereira P; Carvalheira J; Gärtner F
Vet J; 2004 Sep; 168(2):180-5. PubMed ID: 15301767
[TBL] [Abstract][Full Text] [Related]
39. Bcl-2 expression and prognostic significance in feline invasive mammary carcinomas: a retrospective observational study.
Dagher E; Abadie J; Loussouarn D; Fanuel D; Campone M; Nguyen F
BMC Vet Res; 2019 Jan; 15(1):25. PubMed ID: 30630524
[TBL] [Abstract][Full Text] [Related]
40. Expression of multidrug resistance-associated P-glycoprotein in feline tumours.
Van der Heyden S; Chiers K; Vercauteren G; Daminet S; Wegge B; Paepe D; Ducatelle R
J Comp Pathol; 2011; 144(2-3):164-9. PubMed ID: 20880544
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
